Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Appl Mater Interfaces ; 14(11): 13653-13664, 2022 Mar 23.
Article in English | MEDLINE | ID: mdl-35276048

ABSTRACT

A giant enhancement of nearly 100 times is seen in triethylamine response through Ti-Zr-Cr-V-Ni high-entropy alloy nanoparticle (HEA NP)-induced fermi energy control of two-dimensional molybdenum disulfide (MoS2) nanosheets. These Laves-phase HEA NP-decorated MoS2 samples are synthesized using cryomilling followed by 30 h of sonication. The prolonged sonication results in well-exfoliated MoS2 with fairly small (∼10-20 nm) HEA NPs anchored due to cryomilling confirmed by extensive microscopic and spectroscopic examinations. The presence of HEA NPs leads to reduction in edge oxidation of MoS2 as seen from X-ray photoelectron spectroscopy. Moreover, this edge state reduction causes strong Fermi level pinning, which is commonly observed in layered MoS2 with bulk metal electrodes. This leads to target gas-specific carrier-type response and selective oxidation of TEA vapors due to highly catalytically active metals. The resulting composite (MoS2 + NPs) exhibits high response (380% for 2000 ppm TEA vapors) along with selectivity toward TEA at 50 °C. The cross-sensitivity of the composite to other volatile organic compounds and NH3, CO, and H2 has been very minimal. Thus, the highly selective catalytic activity of metal alloy NPs and their Fermi energy control has been proposed as the prime factors for observed large sensitivity and selective response of MoS2 + NP nanocomposites.

2.
J Biomol Struct Dyn ; 39(12): 4449-4461, 2021 Aug.
Article in English | MEDLINE | ID: mdl-32666910

ABSTRACT

Despite the intensive research efforts towards antiviral drug against COVID-19, no potential drug or vaccines has not yet discovered. Initially, the binding site of COVID-19 main protease was predicted which located between regions 2 and 3. Structure-based virtual screening was performed through a hierarchal mode of elimination technique after generating a grid box. This led to the identification of five top hit molecules that were selected on the basis of docking score and visualization of non-bonding interactions. The docking results revealed that the hydrogen bonding and hydrophobic interactions are the major contributing factors in the stabilization of complexes. The docking scores were found between -7.524 and -6.711 kcal/mol indicating strong ligand-protein interactions. Amino acid residues Phe140, Leu141, Gly143, Asn142, Thr26, Glu166 and Thr190 (hydrogen bonding interactions) and Phe140, Cys145, Cys44, Met49, Leu167, Pro168, Met165, Val42, Leu27 and Ala191 (hydrophobic interactions) formed the binding pocket of COVID-19 main protease. From identified hits, ZINC13144609 and ZINC01581128 were selected for atomistic MD simulation and density functional theory calculations. MD simulation results confirm that the protein interacting with both hit molecules is stabilized in the chosen POPC lipid bilayer membrane. The presence of lowest unoccupied molecular orbital (LUMO) and highest occupied molecular orbital (HOMO) in the hydrophobic region of the hit molecules leads to favorable ligand-protein contacts. The calculated pharmacokinetic descriptors were found to be in their acceptable range and therefore confirming their drug-like properties. Hence, the present investigation can serve as the basis for designing and developing COVID-19 inhibitors. Communicated by Ramaswamy H. Sarma.


Subject(s)
COVID-19 , Molecular Dynamics Simulation , Density Functional Theory , Humans , Molecular Docking Simulation , SARS-CoV-2
3.
Bioorg Chem ; 99: 103775, 2020 06.
Article in English | MEDLINE | ID: mdl-32222618

ABSTRACT

We have designed and synthesized 2-methoxy-3-(thiophen-2-ylmethyl)quinoline containing amino carbinols as possible anti-tubercular agents to combat the disease. These molecules were synthesized by tethering amino ether linkage with hydroxyl group to diarylquinoline skeleton; hydroxyl and amine chains were engrafted on diaryl ring. They were evaluated against strain (H37Ra) of Mycobacterium tuberculosis and most of compounds showed in vitro antitubercular activity. Two compounds having diaryl quinoline hydroxyl amino ether scaffold and three compounds having diaryl amino alkyl carbinol core showed activities at 6.25 µg/mL. This study explores diaryl carbinol prototype as inhibitor against Mycobacterium tuberculosis.


Subject(s)
Antitubercular Agents/pharmacology , Methanol/pharmacology , Mycobacterium tuberculosis/drug effects , Antitubercular Agents/chemical synthesis , Antitubercular Agents/chemistry , Dose-Response Relationship, Drug , Methanol/analogs & derivatives , Methanol/chemistry , Microbial Sensitivity Tests , Molecular Structure , Structure-Activity Relationship
4.
Open Access Maced J Med Sci ; 7(7): 1059-1066, 2019 Apr 15.
Article in English | MEDLINE | ID: mdl-31049081

ABSTRACT

AIM: To carry out the comparative nootropic, neuroprotective potentials of two medicinal plant species. MATERIAL AND METHODS: For neuroprotective activity; behavior models (elevated plus maze & morris water maze), in vivo antioxidant (superoxide dismutase, catalase, lipid peroxidation & reduced glutathione), inflammatory markers (IL-1ß, IL-6 & TNF-α) and acetylcholine esterase (AChE) assessment procedures followed at different dosages i.e. 250 & 500 mg/kg of Evolvulus alsinoides and Centella asiatica ethanolic extracts. At the end of the study, it was performed histopathological analysis of the following organs: brain, heart, liver, and kidney. RESULTS: In oral administration of different doses of ethanolic extracts of both medicinal plants i.e. Sco + EEA 250 = 2.49 ± 0.29 , Sco + EEA 500 = 2.67 ± 0.36, Sco + ECA 250 = 2.33 ± 0.17, Sco + ECA 500 = 2.77 ± 0.21, Sco + EEA + ECA 250 = 2.61 ± 0.32 and Sco + EEA + ECA 500 = 2.79 ± 0.16 U/mg of protein respectively against the scopolamine induced group Sco (control) = 5.51 ± 0.35 U/mg of protein extracts shows neuroprotective and nootropic activity with reducing AChE level in the brain homogenate of swiss albino mice. CONCLUSION: Since the E. alsinoides & C. asiatica are already used in traditional Indian medicine as the neuroprotective agent and also found promising effects over inflammatory diseases, wound healing, and immunomodulatory activity. The neuroprotective effect of both plants extracts attributed to inhibition of AChE activity and improve the spatial memory formation.

5.
Open Access Maced J Med Sci ; 7(7): 1071-1076, 2019 Apr 15.
Article in English | MEDLINE | ID: mdl-31049083

ABSTRACT

AIM: We aimed to investigate several parameters after the in vivo acute and sub-acute administration of ethanolic extracts from E. alsinoides & C. asiatica. METHODS: Malignant Ovarian Germ Cell Tumors for in vivo toxicity study guidelines 423 and 407 of Organization for Economic Co-operation and Development (OECD) were followed for acute and sub-acute toxicity assays respectively. For LD50 evaluation, a single dose of ethanolic extracts of Evolvulus alsinoides L. (EEA) and ethanolic extracts of Centella asiatica (ECA) was orally administered to mice at doses of 200, 400, 800, 1600 and 2000 mg/kg. Then the animals were observed for 72 hours. For acute toxicity evaluation, a single dose of both extracts was orally administered to mice at doses of 300, 600, 1200 and 2000 mg/kg and the animals were observed for 14 days. In the sub-acute study, the extracts were orally administered to mice for 28 days at doses of 300, 600, 1200 and 2000 mg/kg. To assess the toxicological effects, animals were closely observed on general behaviour, clinical signs of toxicity, body weight, food and water intake. At the end of the study, it was performed biochemical and hematological evaluations, as well as histopathological analysis from the following organs: brain, heart, liver, and kidney. RESULTS: The oral administration of E. alsinoides and C. asiatica ethanolic extracts, i.e. EEA 300, EEA 600, EEA 1200, EEA 2000, ECA 300, ECA 600, ECA 1200 & ECA 2000 mg/kg doses showed no moral toxicity effect in LD50, acute and sub-acute toxicity parameters. CONCLUSION: In this study, we had found that E. alsinoides & C. asiatica extract at different doses cause no mortality in acute and sub-acute toxicity study. Also, histopathology of kidney, liver, heart, and brain showed no alterations in tissues morphology.

6.
J Biomol Struct Dyn ; 36(7): 1691-1712, 2018 May.
Article in English | MEDLINE | ID: mdl-28521603

ABSTRACT

Despite the various research efforts toward the treatment of stress-related disorders, the drug has not yet launched last 20 years. Corticotropin releasing factor-1 receptor antagonists have been point of great interest in stress-related disorders. In the present study, we have selected benzazole scaffold-based compounds as corticotropin releasing factor-1 antagonists and performed 2D and 3D QSAR studies to identify the structural features to elucidating the binding mechanism prediction. The best 2D QSAR model was obtained through multiple linear regression method with r2 value of .7390, q2 value of .5136 and pred_r2 (predicted square correlation coefficient) value of .88. The contribution of 2D descriptor, T_2_C_1 was 60% (negative contribution) and 4pathClusterCount was 40.24% (positive contribution) in enhancing the activity. Also 3D QSAR model was statistically significant with q2 value of .9419 and q2_se (standard error of internal validation) value of .19. Statistical parameters results prove the robustness and significance of both models. Further, molecular docking and pharmacokinetic analysis was performed to explore the scope of investigation. Docking results revealed that the all benzazole compounds show hydrogen bonding with residue Asn283 and having same hydrophobic pocket (Phe286, Leu213, Ile290, Leu287, Phe207, Arg165, Leu323, Tyr327, Phe284, and Met206). Compound B14 has higher activity compare to reference molecules. Most of the compounds were found within acceptable range for pharmacokinetic parameters. This work provides the extremely useful leads for structural substituents essential for benzimidazole moiety to exhibit antagonistic activity against corticotropin releasing factor-1 receptors.


Subject(s)
Benzimidazoles/chemistry , Corticotropin-Releasing Hormone/antagonists & inhibitors , Corticotropin-Releasing Hormone/chemistry , Binding Sites , Computer Simulation , Drug Design , Hydrogen Bonding , Hydrophobic and Hydrophilic Interactions , Molecular Docking Simulation/methods , Protein Binding , Quantitative Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...